IP Library Granted Patent US 7,018,814
Granted Patent B2
US 7,018,814 · App. 10/943,404 · Granted Mar 28, 2006

Process of purifying vancomycin hydrochloride

Assignee: CJ Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,018,814
App. No.
10/943,404
Granted
Mar 28, 2006
Kind
B2
Abstract

Provided is a method of purifying a vancomycin from a fermentation broth of a microorganism containing vancomycin, including passing the fermentation broth of a microorganism containing vancomycin through a strong acid cation exchange resin, a weak base anion exchange resin, alumina and a hydrophobic absorbent resin sequentially.

Claims (10)

1. A method of purifying vancomycin HCl from a fermentation broth of a microorganism containing vancomycin, comprising:

passing the fermentation broth of a microorganism containing vancomycin through a strong acid cation exchange resin at pH 1–3 and eluting vancomycin with a 0.05 to 0.2 N ammonium hydroxide solution in water having a pH of 9–11;

adjusting a pH of the eluted solution to 3–5, passing the solution through a weak base anion exchange resin and subsequently alumina, and then washing the weak base anion exchange resin and alumina with water to elute vancomycin, and decolorizing vancomycin;

passing the eluted solution through a hydrophobic absorbent resin and eluting vancomycin with an aqueous solution of C1–4 alcohol; and

adding hydrochloric acid to the eluted solution to adjust the pH of the eluted solution to 2–5 and adding an water-soluble organic solvent selected from the group consisting of a C1–4 alcohol, acetonitrile, acetone, and methyl isobutyl ketone to the eluted solution to crystallize vancomycin HCl.

2. The method of claim 1 , wherein the microorganism is Amycolatopisis orientalis.

3. The method of claim 1 , wherein the strong acid cation exchange resin is, a sulfone resin, available which has 50–100 mesh.

4. The method of claim 1 , wherein in the eluting vancomycin with an aqueous solution of C1–4 alcohol and in the adding the water-soluble organic solvent to the eluted solution, a C1–4 alcohol is selected from the group consisting of methanol, ethanol, and isopropanol.

5. The method of claim 1 , further comprising mixing the eluted solution obtained after the decolorizing with activated carbon, and then filtering the resultant mixture.

6. The method of claim 1 , further comprising concentrating the eluted solution obtained after the eluting vancomycin with the aqueous solution of C1–4 alcohol.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2014
From: SAMYANG GENEX CORPORATION
To: SAMYANG BIOPHARMACEUTICALS CORPORATION
Reel/Frame 032666/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2007
From: CJ CORPORATION
To: SAMYANG GENEX CORPORATION; GENOTECH CO., LTD.
Reel/Frame 019817/0771 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2004
From: LEE, JU WON; SUH, JONG WOO; LEE, KWANG SEOB
To: CJ CORPORATION
Reel/Frame 015813/0111 →
Priority Claims (1)
KR 10-2004-0050429 · Jun 30, 2004 · national
Continuity (1)
Related Publication 20060003406A1 · Jan 5, 2006